LYMPHEDEMA TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global lymphedema treatment market is expected to be valued at US$ 570.4 Mn in 2023, and is expected to reach US$ 1,094 Mn by 2030, exhibiting a CAGR of 9.7% during the forecast period.

Lymphedema is a chronic condition that is characterized by localized fluid retention and tissue swelling caused by compromised lymphatic system. Global lymphedema treatment market comprises of therapies and devices used for managing this condition. Compression therapy is the first line of treatment for lymphedema. The therapy applies external pressure to reduce swelling and improve drainage of lymphatic fluid. Other treatments include drug therapy, surgery, pneumatic compression and laser therapy. The market growth is driven by rising prevalence of lymphedema worldwide.

Global Lymphedema Treatment Market- Regional Insights

• North America is expected to be the largest market for lymphedema treatment during the forecast period, accounting for over 37.9% of the market share in 2023. The growth of the market in North America is attributed to the high disease burden, presence of major players, and a well-established healthcare system in the region.
•  Europe is expected to be the second-largest market for lymphedema treatment, accounting for over 29.1% of the market share in 2023. The growth of the market is attributed to rising healthcare expenditure, and increasing awareness about lymphedema treatment in the region.

• Asia Pacific is expected to be the third-largest market for lymphedema treatment, accounting for over 24.5% of the market share in 2023. The growth of the market in Asia Pacific is attributed to improving healthcare infrastructure and increasing disposable income in the region. Moreover, inclination towards minimally invasive procedures is also expected to drive the market growth in this region.

Figure 1. Global Lymphedema Treatment Market Share (%), By Region, 2023

To learn more about this report, request sample copy

Global Lymphedema Treatment Market- Drivers

• Rising prevalence of lymphedema: Rising prevalence of lymphedema across the globe is a major factor driving the global lymphedema treatment market growth. Lymphedema is a chronic condition that leads to swelling in arms or legs due to build-up of lymph fluid. The number of lymphedema cases is increasing steadily due to growing aging population and rising cases of obesity. Lymphedema is more common in elderly due to deterioration of lymph vessels. The growing disease burden is creating significant demand for effective treatment options, thereby, propelling the lymphedema treatment market growth. For instance, in July 2022, according to an article published by National Library of Medicine, 1 in 1,000 Americans have secondary lymphedema, and in 2021, 140 million to 250 million people suffered from lymphedema worldwide.
• Increasing incidence of cancer: Increasing incidence of cancer around the world is anticipated to boost the lymphedema treatment demand during the forecast period. Cancer treatments such as radiation therapy and lymph node removal surgery elevate the risk of developing secondary lymphedema. The rising cancer incidence coupled with growing awareness about lymphedema care is expected to boost treatment adoption among cancer survivors. This is likely to boost the growth of the lymphedema treatment market.
• Technological advancements: Global lymphedema treatment market growth is driven by continuous technological advancements in compression therapy devices and techniques. Companies are developing more portable, effective and smarter compression pumps and garments integrated with features like touchscreen interface, smartphone connectivity and adjustable pressure settings. For instance, Flexitouch Plus, a pneumatic compression device for lymphedema treatment that is manufactured by Tactile Medical, a U.S.-based medical devices manufacturing company, has an advanced pneumatic device that mimics manual lymphatic drainage. Such innovations are improving patient experience, thereby, boosting product demand and market growth.

Global Lymphedema Treatment Market- Opportunities

• Untapped emerging economies: Emerging economies present significant opportunities for lymphedema treatment market players due to the huge untapped patient population and improving healthcare access in these regions. Countries such as China, India, Mexico and Brazil have high lymphedema incidence, owing to endemic parasitic diseases, lifestyle changes causing obesity and rising cancer cases. The healthcare infrastructure is evolving with increasing expenditure and health insurance penetration in these countries, leading to rising treatment adoption.
• Growing awareness campaigns: Global lymphedema treatment market is expected to be favored by growing efforts to spread awareness about the disease and available therapeutic options. Non-profit organizations like Lymphatic Education & Research Network (LE&RN) run awareness programs throughout U.S. on lymphedema in collaboration with healthcare providers, government bodies and companies. For instance, March is celebrated as Lymphedema Awareness Month in the U.S. and Canada. Such initiatives educate patients and caregivers, helping in early diagnosis and access to quality treatment.
• Growing demand for self-management therapies: Increasing demand for self-management therapies due to their convenience and efficacy offers lucrative expansion scope for market players. At-home therapies like simple lymphatic drainage, compression bandaging, remedial exercises and pneumatic compression devices are gaining traction. Companies are developing easy-to-use products suited for home treatment settings. The launch of smart compression pumps with mobile app connectivity has further enabled patient self-management, and is driving the market growth.

Global Lymphedema Treatment Market- Trends

• Smart compression therapy: Smart compression therapy is an emerging trend in the lymphedema treatment industry. Companies are developing compression systems integrated with touchscreen modules, in-build sensors and connectivity features. Rising adoption of such smart compression devices due to benefits such as improved patient adherence and treatment outcomes is expected to boost the market growth.
• Lymphedema self-management: There has been a shift towards self-management of lymphedema, characterized by the growing usage of at-home therapies. Patients are using pneumatic compression devices, undergoing self-massage, wearing compression garments and doing remedial exercises by themselves at home for relief. Digital tools like mobile apps that assist self-management are also gaining popularity. Companies are promoting lymphedema self-management programs and launching easy-to-use at-home products to capitalize on this trend.

Global Lymphedema Treatment Market- Restraints

• Lack of awareness: Low awareness regarding lymphedema and the available treatment approaches acts as a key barrier hindering the market growth. Owing to poor disease knowledge, patients often delay seeking medical care until the condition becomes severe and difficult to manage. Moreover, the social stigma surrounding lymphedema limits treatment-seeking behavior. Limited patient education initiatives on the necessity of therapy compliance further restricts the market potential. Thus, increasing public awareness is crucial for industry expansion.
• High treatment costs: The high cost of lymphedema treatment poses a major challenge for market growth. The therapeutic modalities and compression garments used in lymphedema management are typically expensive. Most patients require lifelong therapy, entailing substantial long-term expenditure. Lack of health insurance coverage for lymphedema treatment in several developing countries such as India, Brazil and others, is also expected to hinder the market growth. For instance, Flexitouch Plus, a pneumatic compression device for lymphedema treatment that is manufactured by Tactile Medical, a U.S.-based medical devices manufacturing company, cost around US$ 5,000 for single unit.

Global Lymphedema Treatment Market- Recent Developments

New Product Launches and Approval:

• In April 2023, AIROS Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy devices for lymphedema treatment, announced that it had received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its AIROS 8P Sequential Compression Therapy device and garment system
• In April 2022, Koya Medical, a healthcare company, announced that it had launched Dayspring active compression system for the treatment of lymphedema and venous diseases in lower extremities

Figure 2. Global Lymphedema Treatment Market Share (%), By Product Type, 2023

To learn more about this report, request sample copy

Top companies in Global Lymphedema Treatment Market:

• Tactile Medical
• AIROS Medical, Inc.
• Bio Compression Systems, Inc.
• Essity Medical SolutionsSigvaris Group
• Lohmann & Rauscher
• Mego Afek ltd.
• ThermoTek
• Medi GmbH
• Compressel
• Huntleigh Healthcare
• JUZO
• Bio Horizons
• medi UK
• Lympha Press
• Paul Hartmann

Definition: Global lymphedema treatment market refers to the industry catering to the diagnosis and management of lymphedema - a chronic condition involving localized fluid retention and swelling caused by compromised lymphatic system. With advancements in treatment modalities and increasing disease burden, the lymphedema treatment market is poised for steady growth over the coming years.

Few Other Promising Reports in Pharmaceutical Industry

India Static Compression Therapy Market

Chronic Myeloid Leukemia Treatment Market

Radial Compression Devices Market

Endovenous Laser Therapy Market